Does Wegovy affect the pill — and does it matter which type you use?

The misconception: Wegovy works like Mounjaro and cancels out the pill

A widely held worry is that all GLP-1 weight-loss medicines reduce oral contraceptive effectiveness in the same way. It is understandable, these medicines share a mechanism of slowing gastric emptying, and the concern follows logically. But the guidance is not identical across the class.

For tirzepatide (Mounjaro), the NHS England weight-management injections guidance explicitly advises adding a barrier method during the first four weeks on each new dose. That instruction reflects trial and prescribing data specific to tirzepatide's dual-receptor mechanism and its effect on the absorption of oral medicines.

Semaglutide, the active ingredient in Wegovy, is a single GLP-1 receptor agonist. The same NHS England resource, and the NHS patient information page for semaglutide, does not carry the equivalent instruction. There is no equivalent directive to switch from the pill or add a barrier method purely because you are starting Wegovy injection. If you are wondering more specifically whether Wegovy affects the pill, the short answer is that the current evidence does not suggest it meaningfully impairs contraceptive effectiveness in the way Mounjaro guidance implies. Correcting this confusion matters, because some people have changed their contraception unnecessarily, or held back from starting treatment out of an unfounded concern.

That does not mean you should make no adjustments at all. It means the adjustment required differs from what Mounjaro users are told, and you should go through the specifics with whoever is prescribing.

Why slowed gastric emptying does not automatically mean the pill fails

GLP-1 medicines delay the movement of food through the stomach. In theory, this could slow the absorption of any oral medicine taken at the same time, including the pill. In practice, pharmacokinetic studies of semaglutide have not demonstrated a reduction in oral contraceptive exposure large enough to be clinically relevant for most people.

The pill's hormones are absorbed across a fairly wide window, and the levels needed to suppress ovulation have a meaningful margin. A modest delay in absorption does not necessarily push concentration below the threshold that matters. This is different from a scenario where a medicine chemically degrades the pill's hormones or speeds up how quickly the liver clears them, Wegovy does neither of those things. Our page looking at how Wegovy affects birth control pills goes into the pharmacokinetic detail for anyone who wants to understand the evidence behind that conclusion.

If you are interested in how the tablet form compares with the injection overall, the page on whether the Wegovy pill works as well as the injection covers the evidence on weight-loss outcomes in more detail. And if cost is part of your thinking, our Wegovy tablet pricing page sets out what private treatment includes.

One practical point worth raising: if you experience significant vomiting, particularly in the first few weeks of treatment, the standard missed-pill rules apply. Persistent vomiting within three to four hours of taking the pill may reduce absorption regardless of which weight-loss medicine you are on. Your prescriber and the patient information leaflet for your specific contraceptive are the right references for what to do if that happens.

What to discuss with a prescriber before you start

A prescriber who knows your full medicine list is best placed to advise. At nume, a GPhC-registered Independent Prescriber reads every consultation personally; your contraceptive method is part of the clinical picture, not an afterthought. Consultations are reviewed the same day, for many people that means before the afternoon school run if they submit in the morning.

A few things worth raising or noting in your consultation form: which type of pill you take (combined oestrogen-progestogen or progestogen-only), whether you have any history of reduced absorption or bowel conditions, and whether you are at a point in life where pregnancy is something you are actively considering. The guidance is clear that Wegovy is not recommended during pregnancy, breastfeeding, or when actively trying to conceive, and a wash-out period before conception is advised.

If you are exploring weight-loss options more broadly, our weight-loss treatment overview covers the licensed medicines available through nume and what each one involves. The team behind our clinical decisions is introduced on the clinical team page.

For anyone who has questions about the oral form of semaglutide specifically (the newer tablet rather than the injection) the semaglutide tablets page explains how it works and who it is licensed for. The interaction picture for the tablet is broadly similar to the injection, but the morning-routine requirements (taken on an empty stomach, at least 30 minutes before food or other oral medicines) do add a practical layer that is worth planning around if you also take the pill at a fixed time each day.

The short version, plainly put

Injectable Wegovy is not currently understood to meaningfully impair oral contraceptive effectiveness. It is not the same situation as Mounjaro, where the guidance is more specific. That does not mean contraception is irrelevant to your consultation, it is directly relevant, because pregnancy on a weight-loss medicine is not recommended and a wash-out period matters before trying to conceive.

If you are unsure how Wegovy fits with your current contraceptive method, or you want to talk through the oral versus injectable options, speaking to a prescriber before you start is the right move. Our about page explains how the service works, and you can look up questions about the medicines through our FAQs. When you are ready, the place to start is a free consultation with our clinical team.

Speak to our prescribers, start your free consultation today.